Treatment Information

Back

Prostate Cancer treatment details. Chemotherapy.

BC Cancer Agency, Vancouver, BC, Canada.

Survival: monthsCountry:Canada
Toxiciy Grade:4City/State/Province:Vancouver, BC
Treatments:ChemotherapyHospital:BC Cancer Agency
Drugs:Journal:Link
Date:Jan 2012

Description:

Patients:
This phase 2 study involved 83 metastatic castration-resistant prostate cancer patients who had been previously treated with docetaxel. The median patient age was 67 years.

Treatment:
Patients were treated with the chemotherapy agent patupilone.

Toxicities:
The most severe toxicities were of grade 4. Grade 3-4 toxicities included diarrhea, fatigue, anorexia, and pain.

Results:
The median overall survival was 11.3 months.

Support:
This study was supported by Novartis, makers of patupilone.

Correspondence: Dr. K. N. Chi; email: [email protected]



Back